HPGC Renmintongtai Pharmaceutical Corp (600829) — Cash Flow Quality Index
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Cash Flow Quality Index of -4.77x as of September 2025. Operating cash flow of CN¥-187.38 Million is below net income of CN¥39.30 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 600829 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HPGC Renmintongtai Pharmaceutical Corp Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for HPGC Renmintongtai Pharmaceutical Corp across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of HPGC Renmintongtai Pharmaceutical Corp.
Annual Cash Flow Quality Index for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Year-by-year earnings quality comparison for HPGC Renmintongtai Pharmaceutical Corp.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.24x | CN¥299.98 Million | CN¥133.84 Million | ▲ +314.1% |
| 2024 | 0.54x | CN¥115.44 Million | CN¥213.27 Million | ▼ -52.5% |
| 2023 | 1.14x | CN¥332.99 Million | CN¥292.16 Million | ▼ -2.3% |
| 2022 | 1.17x | CN¥307.33 Million | CN¥263.41 Million | ▲ +238.5% |
| 2021 | -0.84x | CN¥-233.00 Million | CN¥276.51 Million | ▼ -1224.5% |
| 2020 | -0.06x | CN¥-9.22 Million | CN¥144.96 Million | ▲ +95.9% |
| 2019 | -1.54x | CN¥-411.60 Million | CN¥267.30 Million | ▼ -208.4% |
| 2018 | 1.42x | CN¥366.45 Million | CN¥257.85 Million | ▲ +159.8% |
| 2017 | 0.55x | CN¥139.07 Million | CN¥254.20 Million | ▲ +167.0% |
| 2016 | 0.20x | CN¥46.01 Million | CN¥224.51 Million | ▼ -91.9% |
| 2015 | 2.52x | CN¥333.99 Million | CN¥132.54 Million | ▼ -83.2% |
| 2014 | 14.97x | CN¥392.58 Million | CN¥26.23 Million | ▲ +2287.9% |
| 2012 | 0.63x | CN¥221.57 Million | CN¥353.49 Million | ▲ +324.8% |
| 2011 | -0.28x | CN¥-108.30 Million | CN¥388.48 Million | ▼ -158.0% |
| 2010 | 0.48x | CN¥162.99 Million | CN¥339.38 Million | ▼ -68.5% |
| 2009 | 1.53x | CN¥447.82 Million | CN¥293.52 Million | ▲ +749.5% |
| 2008 | -0.23x | CN¥-65.93 Million | CN¥280.68 Million | ▼ -133.4% |
| 2007 | 0.70x | CN¥191.10 Million | CN¥271.83 Million | ▼ -20.8% |
| 2006 | 0.89x | CN¥191.13 Million | CN¥215.32 Million | ▼ -43.3% |
| 2005 | 1.57x | CN¥313.04 Million | CN¥199.80 Million | ▲ +4.8% |
| 2004 | 1.50x | CN¥60.69 Million | CN¥40.59 Million | ▼ -62.9% |
| 2003 | 4.03x | CN¥71.65 Million | CN¥17.79 Million | ▼ -68.1% |
| 2002 | 12.61x | CN¥127.49 Million | CN¥10.11 Million | ▲ +3668.1% |
| 2001 | 0.33x | CN¥14.79 Million | CN¥44.21 Million | ▼ -66.7% |
| 2000 | 1.01x | CN¥61.85 Million | CN¥61.54 Million | ▼ -96.0% |
| 1999 | 25.06x | CN¥58.21 Million | CN¥2.32 Million | ▼ -52.3% |
| 1998 | 52.50x | CN¥41.00 Million | CN¥780.86K | — |